In recent years, AI technology has developed to incredible heights and its potential applications in the sciences have been exponentially increasing. From self-driving cars to unlocking the mysteries of dark matter, artificial intelligence has become a powerful tool of unprecedented breadth. Now, scientists are exploring another possible use for AI: generating original proteins from scratch…
Read MoreNews Claritas Genomics to Present 4 Posters and a Talk ‘Phenotype First: The Power of a Tailored Exome’ at ACMG Annual Clinical Genetics Meeting CAMBRIDGE, Mass., March 24, 2015 /PRNewswire-USNewswire/ — Claritas Genomics will present data on the quality of parallel multi-technology sequencing, a comparison of the company’s phenotypically driven Pediatric Neurology Exome Assay to whole exome…
Read MoreCAMBRIDGE, Mass., March 24, 2015 /PRNewswire-USNewswire/ — Claritas Genomics will present data on the quality of parallel multi-technology sequencing, a comparison of the company’s phenotypically driven Pediatric Neurology Exome Assay to whole exome and panel-based approaches, three-part reports for rapid results reporting, and the clinical utility of the Neurology Exome’s tailored approach compared to other tests currently…
Read MoreJuly 23, 2014: Dr. Yiping Shen, a Clinical Genetics Medical Director at Claritas Genomics presented a webinar sponsored by Agilent Technologies on Claritas’s ClariView Array, a microarray designed for patients with autism, developmental delay, or intellectual disability. More information about the webinar can be found by visiting Agilent’s website. Visit the ClariView Array webpage to…
Read MoreJanuary 8, 2013 Spinoff venture will develop genomic sequencing solutions utilizing Ion Torrent technology for clinical applications SAN FRANCISCO, Jan. 8, 2013 /PRNewswire-USNewswire/ — Boston Children’s Hospital has partnered with Life Technologies Corporation(NASDAQ: LIFE) to launch Claritas Genomics, a new company formed to develop next-generation, genetic and genomics-based diagnostic testing solutions. The venture combines advanced instrumentation, software and bioinformatics capabilities with sophisticated clinical…
Read MoreClaritas Genomics is pleased to announce that it is now a Certified Service Provider in the Life Technologies Ion AmpliSeq™ Exome network. Through this program, Claritas Genomics offers Ion AmpliSeq™ Exome Sequencing Research Services using the Ion Proton System. Researchers will receive high-quality sequencing data and will have access to the Ion Reporter™ software for annotation and further analysis. Base…
Read MoreCAMBRIDGE, Mass., Dec. 11, 2014 To rapidly expand the use and power of genomic sequencing for diagnosing and treating rare diseases, Claritas Genomics and NextCODE Health today announced a strategic partnership bringing together global leadership in pediatric medicine and sequence analysis. Claritas Genomics, affiliated with Boston Children’s Hospital, is a CLIA-certified clinical laboratory serving the DNA-based…
Read MoreElizabeth Boudreau, Claritas’s Senior Manager of Information Technology, was invited by Amazon Web Services to speak at the June conference in Washington, DC. The conference, “AWS Government, Education, and Nonprofits Symposium,” invited leaders in public sectors to learn more about how the AWS cloud can support their work. Ms. Boudreau’s presentation, entitled “Enhancing Genetic Computation…
Read MoreFOR IMMEDIATE RELEASE Nov 12, 2013 Pediatric hospitals to share data and genomic testing infrastructure for the benefit of patients Cambridge, Nov 12— Cincinnati Children’s Medical Center has partnered with Claritas Genomics, a company formed by Boston Children’s Hospital and Life Technologies Corporation (NASDAQ: LIFE), to provide genomics-based diagnostics for pediatric patients. Cincinnati Children’s will work…
Read MoreOn May 1, 2014 at the Executive War College in New Orleans, Patrice spoke about Claritas Genomics’ evolution into a national genetic testing company. The title of her presentation was “Claritas Genomics: Transforming a Hospital-Based Molecular Lab into a Next-Generation Pediatric Diagnostic Company.”
Read More